FMP

FMP

Enter

HOOK - HOOKIPA Pharma Inc.

Profile of HOOKIPA Pharma Inc.(HOOK), HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeti

About

ceo

Mr. Joern Aldag

sector

Healthcare

industry

Biotechnology

website

https://www.hookipapharma.com

exchange

NASDAQ

Description

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

CIK

0001760542

ISIN

US43906K1007

CUSIP

43906K100

Address

350 Fifth Avenue

Phone

431 890 6360

Country

US

Employee

151

IPO Date

Apr 18, 2019

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep